COCP

$0.00

(

+0.00%

)
Quote details

stock

Cocrystal Pharma Inc

NASDAQ | COCP

1.70

USD

+0.00

(

+0.00%

)

AT CLOSE (AS OF Aug 15, 2025)

$17M

MARKET CAP

-

P/E Ratio

-1.56

EPS

$3.3

52 Week High

$1.1

52 Week Low

LIFE SCIENCES

Sector

COCP Chart

Recent Chart
Price Action
1D
Candles

Trade Smarter

Automate your trading workflow with powerful tools — built for serious traders.

Icon For Time-schedule

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Icon For Search

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Icon For Clipboard-list

Journal

Record your trades and performance to improve your trading with AfterPullback's Trading Journal

COCP Technicals

Tags:

COCP Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$18M
Selling General And Administrative $5.3M
Research And Development $13M
Operating Expenses $18M
Investment Income Net -
Net Interest Income $537K
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $446K
Income Before Tax -$18M
Income Tax Expense -$18M
Interest And Debt Expense -
Net Income From Continuing Operations -$18M
Comprehensive Income Net Of Tax -
Ebit -$18M
Ebitda -$17M
Net Income -$18M

Revenue & Profitability

Earnings Performance

COCP Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $13M
Total Current Assets $12M
Cash And Cash Equivalents At Carrying Value $9.9M
Cash And Short Term Investments $9.9M
Inventory -
Current Net Receivables $1.2M
Total Non Current Assets $1.9M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $505K
Other Non Current Assets -
Total Liabilities $3.9M
Total Current Liabilities $2.4M
Current Accounts Payable $1.5M
Deferred Revenue -
Current Debt -
Short Term Debt $602K
Total Non Current Liabilities $1.5M
Capital Lease Obligations $1.8M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $1.8M
Other Current Liabilities $234K
Other Non Current Liabilities -
Total Shareholder Equity $9.5M
Treasury Stock -
Retained Earnings -$333M
Common Stock $10K
Common Stock Shares Outstanding $10M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$16M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $126K
Capital Expenditures $8K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$8K
Cashflow From Financing $0
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$18M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$18M
Selling General And Administrative $5.3M
Research And Development $13M
Operating Expenses $18M
Investment Income Net -
Net Interest Income $537K
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $446K
Income Before Tax -$18M
Income Tax Expense -$18M
Interest And Debt Expense -
Net Income From Continuing Operations -$18M
Comprehensive Income Net Of Tax -
Ebit -$18M
Ebitda -$17M
Net Income -$18M

COCP News

COCP Profile

Cocrystal Pharma Inc Profile

Sector: LIFE SCIENCES

Industry: PHARMACEUTICAL PREPARATIONS

Cocrystal Pharma, Inc., a biotechnology company, is focused on the discovery and development of antiviral therapeutic treatments for serious and / or chronic viral diseases. The company is headquartered in Bothell, Washington.

Discover more tools and features to empower your trading
Explore Features

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.